Biochemical and Biophysical Research Communications
Volume 281, Issue 2, 23 February 2001, Pages 361-366
Regular ArticleInterleukin-18 Up-Regulates Osteoprotegerin Expression in Stromal/Osteoblastic Cells
References (33)
Cell biology of the osteoclast
Exp. Hematol.
(1999)- et al.
Interleukin-18: A novel cytokine that augments both innate and acquired immunity
Adv. Immunol.
(1998) - et al.
Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
Cell
(1997) - et al.
IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP
J. Biol. Chem.
(1996) - et al.
Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling
J. Biol. Chem.
(1998) - et al.
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
Cell
(1998) - et al.
Purification and characterization of the human interleukin-18 receptor
J. Biol. Chem.
(1997) - et al.
Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function
Immunity
(1998) - et al.
Interleukin-18 induces activation and association of p56lck and MAPK in a murine TH1 clone
Biochem. Biophys. Res. Commun.
(1997) - et al.
Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation
Biochem. Biophys. Res. Commun.
(1999)
Transforming growth factor-β stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells
J. Biol. Chem.
(1998)
Transforming growth factor-β1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells
Biochem. Biophys. Res. Commun.
(1998)
Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-κB ligand: Modulation of the expression by osteotropic factors and cytokines
Biochem. Biophys. Res. Commun.
(2000)
The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function
J. Biol. Chem.
(2000)
MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1
J. Biol. Chem.
(2000)
Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families
Endocr. Rev.
(1999)
Cited by (0)
- 1
To whom correspondence should be addressed at First Department of Pathology, Hyogo College of Medicine, 1-1, Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan. Fax: +81-798-45-6431. E-mail: [email protected].
Copyright © 2001 Academic Press. All rights reserved.